All lobbying filings

AMERICAN SOCIETY FOR MICROBIOLOGY

Lobbying for AMERICAN SOCIETY FOR MICROBIOLOGY

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 10

S 4048
PREDICT Act
HR 5269
RESULTS Act
S 2761
RESULTS Act
HR 1864
Risky Research Review Act
S 854
Risky Research Review Act
HR 2756
National Biotechnology Initiative Act of 2025
S 1387
National Biotechnology Initiative Act of 2025
HR 2582
Expanding Partnerships for Innovation and Competitiveness Act
S 1235
Expanding Partnerships for Innovation and Competitiveness Act
S 2676
Cloud LAB Act of 2025

Lobbying activity 4

Health Issues

Antimicrobial resistance; advanced molecular detection; national wastewater surveillance system (S.4048 - PREDICT Act), PAMA reform: RESULTS Act (H.R. 5269 S.2761)

Budget/Appropriations

Fiscal Year 2027 appropriations for NIH, CDC, NSF, DOE Office of Science, USDA research programs.

Science/Technology

Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);

Agriculture

Microbiome research impact on agricultural sciences.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.